BRISTOL SCIENTIST CHALLENGES NEW STUDY ON POWERLINES AND CHILDHOOD LEUKAEMIA

Main Menu | News By Date | News By Supplier | News By Category | About Us

BRISTOL SCIENTIST CHALLENGES NEW STUDY ON POWERLINES AND CHILDHOOD LEUKAEMIA
01 May 2007 - University of Bristol

In response to the study by Dr David Lloyd and colleagues published in the British Journal of Cancer today, Professor Denis Henshaw of Bristol University has questioned whether the study provides evidence that powerlines do not cause childhood leukaemia, given the already acknowledged link between childhood leukaemia risk and exposure to magnetic fields, such as those found near high voltage powerlines.

Two major pooled analyses of international studies published in 2000, by Professor Anders Ahlbom of the Karolinska Institute in Stockholm and Professor Sander Greenland of the University College of Los Angeles have clearly demonstrated that there is a doubling of childhood leukaemia risk associated with magnetic field exposures above 0.3 or 0.4 microtesla, well below that found under high voltage powerlines.

Many lines of investigation have been followed in searching for mechanisms by which magnetic fields may cause an increase in childhood leukaemia risk. One such line concerns the ability of magnetic fields to disrupt both the production and action in the body of the natural anti-cancer agent melatonin. At magnetic field levels as low as 0.2 microtesla, again well below that typically seen under high voltage powerlines, there are at least nine studies in human population groups showing that such fields reduce the night-time production of melatonin in the pineal gland.

The study carried out by Dr Lloyd and colleagues did not involve melatonin. Therefore, while publication of this study is to be welcomed, failure to observe an effect of magnetic fields on these cells may be unsurprising. In particular, the study does not provide evidence that exposure to magnetic fields near powerlines does not cause childhood leukaemia.

Studies on breast cancer cells in the laboratory have shown that while melatonin can inhibit the growth of these cells, this inhibiting action can be suppressed by magnetic fields, again at levels lower than that typically seen under powerlines. No such studies have been done on blood cells. However, it is known that melatonin is highly protective of radiation damage to blood cells of the type looked at in Dr Lloyd's study and the type that could lead to leukaemia. If magnetic fields, which disrupt the production of melatonin in the pineal gland, also inhibit its protective action that has been shown for breast cancer cells, then clearly this would provide a potential mechanism by which magnetic fields such as seen near powerlines increase the risk of childhood leukaemia.

http://www.bris.ac.uk

About: University of Bristol
The University College of Bristol opened in 1876, after six years of discussions and controversy, in a bid to bring university culture to the provinces. It was the first college in the country to admit men and women on an equal footing.

The University’s Research and Enterprise Development (RED) division was launched in 2000 to stimulate and support an entrepreneurial culture and encourage the growth of technology-based business.

2003 saw the completion of the Dorothy Hodgkin building, named after the University’s fifth Chancellor. The £18 million building is dedicated to research in neuroendocrinology. 2003 also saw the opening of the University’s £5 million Centre for Sport, Exercise and Health.

Work on a new, state-of-the-art engineering building is due to be completed in early 2004. The £20 million BLADE project (Bristol Laboratory for Advanced Dynamics Engineering) will bring together the Engineering Faculty’s six departments to establish Europe’s most advanced dynamics engineering research facilities.

More News:
  • For May 2007
  • From University of Bristol
  • For Superconductors